- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04980378
Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc
April 1, 2024 updated by: NuVasive
This study is intended to demonstrate the 5-year long-term safety and efficacy of the Simplify® Cervical Artificial Disc ("Simplify Disc") in subjects enrolled in the non-randomized two-level Simplify Disc Investigational Device Exemption (IDE) study.
This study was conducted under IDE G150206
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
157
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Orange, California, United States, 92868
- Orthopaedic Education and Research Institute of Southern California
-
Santa Monica, California, United States, 90403
- The Spine Institute for Spine Restoration
-
-
Colorado
-
Thornton, Colorado, United States, 80229
- Spine Education and Research Foundation
-
-
Connecticut
-
Hamden, Connecticut, United States, 06518
- Connecticut Orthopaedic Specialists
-
-
Florida
-
Sarasota, Florida, United States, 34232
- Kennedy-White Orthopedic Center
-
-
Illinois
-
Evanston, Illinois, United States, 60201
- NorthShore University Health System
-
-
Indiana
-
Carmel, Indiana, United States, 46032
- Indiana Spine Group
-
Fort Wayne, Indiana, United States, 46845
- Parkview Research Center
-
-
Kentucky
-
Paducah, Kentucky, United States, 42003
- Orthopaedic Institute of Western Kentucky
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71101
- Spine Institute of Louisiana
-
-
Michigan
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital Research Institute
-
-
New York
-
Lockport, New York, United States, 14094
- Buffalo Spine Surgery
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Carolina Neurosurgery and Spine Associates
-
-
Oregon
-
Springfield, Oregon, United States, 97477
- Oregon Neurosurgery
-
-
Texas
-
Addison, Texas, United States, 75001
- Texas Spine Consultants
-
Plano, Texas, United States, 75093
- Texas Back Institute
-
-
Utah
-
West Jordan, Utah, United States, 84088
- The Disc Replacement Center
-
-
Virginia
-
Reston, Virginia, United States, 20191
- Virginia Spine Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population will include subjects who were enrolled in the IDE study G150206.
This will include up to 170 subjects eligible for study enrollment from sixteen (16) sites in the two level Simplify Disc IDE study who consent to long-term follow-up.
Additionally, up to 17 training subjects from the two level Simplify Disc IDE study from seventeen (17) sites will be enrolled.
Description
Inclusion Criteria:
- All subjects enrolled in the two level Simplify Disc IDE study are considered for this long-term follow-up study.
Exclusion Criteria:
- Subjects who were not implanted with the Simplify Disc during the IDE study
- Subjects who had a secondary surgical intervention at the index level during the IDE study
- Subjects who were withdrawn or withdrew consent to participate in the IDE study
- Subjects who do not consent to participate in long-term follow-up post-approval study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Simplify Disc
Extended follow-up of IDE Subjects treated at two continuous levels with the Simplify Cervical Artificial Disc during IDE G150206
|
The Simplify Disc is a cervical artificial disc manufactured from polyether ether ketone (PEEK) endplates and a mobile, zirconia-toughened alumina ceramic core.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Composite Success
Time Frame: 60 Months
|
Individual success for Simplify Disc is defined as follows:
|
60 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinically significant improvement in one or more radicular symptoms or myelopathy
Time Frame: 60 Months
|
Clinically significant improvement in one or more radicular symptoms or myelopathy at each annual timepoint compared to baseline in the IDE study for the two level Simplify Disc.
Endpoints will be graded based on pain questionnaires, motor status, and sensory status.
|
60 Months
|
Time to recovery
Time Frame: 60 Months
|
Time to recovery defined as the earliest time at which a minimum 15-point (out of 100) NDI improvement is reached.
|
60 Months
|
Disc Height
Time Frame: 60 Months
|
Disc height at each annual timepoint compared to baseline (6 weeks) in the IDE study for the two level Simplify Disc.
Both levels had to be a disc height success to claim success for overall disc height.
This will be graded by the radiographic core laboratory.
|
60 Months
|
Adjacent Level Deterioration
Time Frame: 60 Months
|
Adjacent level deterioration at each annual timepoint compared to baseline in the investigational group of the IDE study for the two level Simplify Disc.
This will be graded by the radiographic core laboratory.
|
60 Months
|
Displacement or Migration of the Device
Time Frame: 60 Months
|
Displacement or migration of the device will be compared to baseline in the IDE.
This will be graded by the radiographic core lab.
|
60 Months
|
Work Status
Time Frame: 60 Months
|
Return to work status post-operatively.
The subjects will be surveyed for this at each follow-up visit
|
60 Months
|
Patient Satisfaction
Time Frame: 60 Months
|
Patient satisfaction and perceived effect at each annual timepoint.
Success will be graded via a survey response of 'Definitely True' or 'Mostly True'
|
60 Months
|
Health Survey; 36-Item Short Form Survey (SF-36)
Time Frame: 60 Months
|
Health Survey at each annual timepoint compared to baseline.
|
60 Months
|
Dysphagia Handicap Index (DHI scale)
Time Frame: 60 Months
|
Dysphagia Handicap Index (DHI scale) for the Simplify Disc at 60 months compared to baseline in the two level IDE study.
|
60 Months
|
Adjacent Level Motion (Stability)
Time Frame: 60 Months
|
Adjacent Level Motion (Stability) will be compared at 60 months to baseline.
This will be graded by the radiographic core lab.
|
60 Months
|
Physician's Perception
Time Frame: 60 Months
|
Results at 60 months will be categorized by the physician's perception of the subject's condition (excellent, good, fair, or poor).
|
60 Months
|
Gait Assessment
Time Frame: 60 Months
|
Gait assessment at 60 months compared to baseline.
This will be based on Nurick's classification.
Success will be defined as maintenance or improvement in the post-operative status as compared to the pre-operative condition.
|
60 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2021
Primary Completion (Actual)
January 24, 2024
Study Completion (Actual)
January 24, 2024
Study Registration Dates
First Submitted
July 19, 2021
First Submitted That Met QC Criteria
July 19, 2021
First Posted (Actual)
July 28, 2021
Study Record Updates
Last Update Posted (Actual)
April 3, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P200022_S003_PAS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Degenerative Disc Disorder
-
NuVasiveActive, not recruitingCervical Degenerative Disc DisorderUnited States
-
NuVasiveCompletedCervical Degenerative Disc DisorderUnited States
-
Spinal KineticsRecruitingCervical Disc Degenerative DisorderUnited States
-
Zimmer BiometCompletedCervical Disc Degenerative DisorderUnited States
-
Medtronic Spinal and BiologicsCompletedDegenerative Cervical Disc DiseaseSaudi Arabia, Greece, Serbia, Hungary, Czech Republic, Kuwait, Poland, Slovakia
-
NuVasiveCompletedCervical Disc Degenerative DisorderUnited States
-
Assiut UniversityNot yet recruiting
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Synergy Spine SolutionsMCRANot yet recruitingCervical Degenerative Disc DiseaseUnited Kingdom
-
Medtronic Spinal and BiologicsCompletedCervical Degenerative Disc DiseaseUnited States
Clinical Trials on Simplify Disc
-
NuVasiveCompletedCervical Degenerative Disc DisorderUnited States
-
NuVasiveEnrolling by invitationDegenerative Disc Disease | Cervical Disc DiseaseUnited States
-
NuVasiveEnrolling by invitationDegenerative Disc Disease | Cervical Disc DiseaseUnited States
-
NuVasiveCompletedCervical Degenerative Disc DiseaseUnited States
-
NuVasiveActive, not recruitingCervical Degenerative Disc DisorderUnited States
-
SpinalMotionTerminatedDegenerative Disc DiseaseUnited States
-
Woebot HealthCompleted
-
Tetec AGCompletedIntervertebral Disc Displacement | Intervertebral Disc DegenerationGermany, Austria
-
Aesculap Implant SystemsCompletedDegenerative Disc DiseaseUnited States